Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 19.05.2025 1 BMJ 3 Clin Infect Dis 1 J Gen Virol 2 J Infect Dis 1 Nat Immunol 1 Nat Med 1 Pediatr Infect Dis J 1 PLoS Comput Biol 9 PLoS One 2 Science 31 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. DYER C
   GP who sought help to supply fake covid vaccine certificates is suspended for 12 months.
   BMJ. 2025;388:r257.
   PubMed        
   
   

   
   Clin Infect Dis

2. REGAN JJ, Wang Z, Phares CR
   The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
   Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
   PubMed         Abstract available
   
   
3. KONOPNICKI D, Gilles C, Manigart Y, Barlow P, et al
   Immunogenicity and safety of two versus three doses of 9-valent vaccine against Human papillomavirus (HPV) in women with HIV: the Papillon randomized trial.
   Clin Infect Dis. 2025 May 13:ciaf241. doi: 10.1093.
   PubMed         Abstract available
   
   
4. AMARIN JZ, Toepfer AP, Spieker AJ, Hayek H, et al
   Respiratory Syncytial Virus Co-Detection With Other Respiratory Viruses Is Not Significantly Associated With Worse Clinical Outcomes Among Children Aged <2 Years: New Vaccine Surveillance Network, 2016-2020.
   Clin Infect Dis. 2025 May 9:ciaf194. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Gen Virol

5. AHMED MN, Abu Habib US, Abdallah AM, Emara MM, et al
   The impact of pre-existing immunity on the emergence of within-host immune-escape mutations in Omicron lineages.
   J Gen Virol. 2025;106:002108.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. ZHU S, Quint J, Leon T, Sun M, et al
   Estimating Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Using Linked Public Health Information Systems, California, 2023-2024 Season.
   J Infect Dis. 2025 May 13:jiaf248. doi: 10.1093.
   PubMed         Abstract available
   
   
7. RUBENS JH, Brockhurst JK, Ghimire S, Wu J, et al
   Safety, immunogenicity, and protective efficacy in rhesus macaques of a novel recombinant hemagglutinin protein measles virus vaccine.
   J Infect Dis. 2025 May 13:jiaf244. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Nat Immunol

8. KWON DI, Mao T, Israelow B, Santos Guedes de Sa K, et al
   Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice.
   Nat Immunol. 2025 May 13. doi: 10.1038/s41590-025-02156.
   PubMed         Abstract available
   
   

   
   Nat Med

9. O'LEARY K
   Measles to become endemic in the USA if vaccination rates continue to fall.
   Nat Med. 2025 May 14. doi: 10.1038/d41591-025-00031.
   PubMed        
   
   

   
   Pediatr Infect Dis J

10. FAFI I, Cohen R, Levy C, Varon E, et al
    High Mortality Due to Pneumococcal Meningitis in Children With Sickle Cell Disease: A French Multicenter Observational Study From 2001 to 2021.
    Pediatr Infect Dis J. 2025;44:496-502.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

11. QU Z, Patterson D, Zhao L, Ponce J, et al
    Mathematical modeling of malaria vaccination with seasonality and immune feedback.
    PLoS Comput Biol. 2025;21:e1012988.
    PubMed         Abstract available
    
    

    
    PLoS One

12. SOARES P, Gomez V, Gaio V, Santos JA, et al
    A protocol for high-dose quadrivalent influenza vaccine effectiveness in the community and long-term care facilities using electronic health records.
    PLoS One. 2025;20:e0314177.
    PubMed         Abstract available
    
    
13. BELICHENKO PV, Madani R, Rey-Bellet L, Pihlgren M, et al
    Correction: An Anti-beta-Amyloid vaccine for treating cognitive deficits in a mouse model of down syndrome.
    PLoS One. 2025;20:e0324280.
    PubMed         Abstract available
    
    
14. ELKARHAT Z, Tifrouin I, Bamouh Z, Tadlaoui KO, et al
    First identification of ORF virus causing contagious ecthyma in Morocco (MOR20): Genomic, phylogenetic, and sequence variants analyses for vaccine design.
    PLoS One. 2025;20:e0323383.
    PubMed         Abstract available
    
    
15. OYEDEJI O, North C, Kintziger KW, Ehrlich S, et al
    Understanding young adults' perceptions regarding human papillomavirus vaccination: A qualitative study.
    PLoS One. 2025;20:e0323063.
    PubMed         Abstract available
    
    
16. LANG HP, Almeer FF, Jenkins MK, Friedenberg SG, et al
    Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs.
    PLoS One. 2025;20:e0323823.
    PubMed         Abstract available
    
    
17. XIA Z, Meng J, Wang X, Liu P, et al
    Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: A meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0321511.
    PubMed         Abstract available
    
    
18. SHIN E, Yun JS, Lee YR, Cha HR, et al
    Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.
    PLoS One. 2025;20:e0322147.
    PubMed         Abstract available
    
    
19. NASIR M, Weeks WB, Gholami S, Marfin A, et al
    Modeling protective meningococcal antibody responses and factors influencing antibody persistence following vaccination with MenAfriVac using machine learning.
    PLoS One. 2025;20:e0323384.
    PubMed         Abstract available
    
    
20. KIM SH, Jung M
    Disentangling behavioral determinants of seasonal influenza vaccination in post-corona era: An integrated model approach.
    PLoS One. 2025;20:e0323184.
    PubMed         Abstract available
    
    

    
    Science

21. WADMAN M
    Mosquito-borne viral disease sweeps Indian Ocean islands.
    Science. 2025;388:690-691.
    PubMed         Abstract available
    
    
22. WILLIS JR, Prabhakaran M, Muthui M, Naidoo A, et al
    Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
    Science. 2025 May 15:eadr8382. doi: 10.1126/science.adr8382.
    PubMed         Abstract available
    
    

    
    Vaccine

23. VARMA A, Bolotin S, De Serres G, Didierlaurent AM, et al
    What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.
    Vaccine. 2025;57:127187.
    PubMed         Abstract available
    
    
24. KUMARI M, Su SC, Lin HT, Ko SH, et al
    Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue.
    Vaccine. 2025;57:127216.
    PubMed         Abstract available
    
    
25. PEARCE A, Henery P, Dundas R, Katikireddi SV, et al
    Socio-economic inequalities in uptake and timing of childhood vaccination: Taking a life course approach in an administrative cohort in Scotland.
    Vaccine. 2025;57:127222.
    PubMed         Abstract available
    
    
26. MOU J, LaSalle G, Pflugeisen C, Sherls-Jones J, et al
    Practice, beliefs and intent in influenza vaccination among Hispanic patients during the pandemic: An interventional study.
    Vaccine. 2025;58:127207.
    PubMed         Abstract available
    
    
27. LE DOARE K, Benassi V, Cavaleri M, Enwere G, et al
    Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countries.
    Vaccine. 2025;58:127131.
    PubMed         Abstract available
    
    
28. SPURGERS K, Wynn M, Charles L, Hamm S, et al
    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the emergent vesicular stomatitis virus (VSV) viral vector vaccine for Lassa fever.
    Vaccine. 2025;58:127137.
    PubMed         Abstract available
    
    
29. WANG-LU H, Valerio Mendoza OM, Chen S, Geldsetzer P, et al
    Regional mobility and COVID-19 vaccine hesitancy: Evidence from China.
    Vaccine. 2025;58:127179.
    PubMed         Abstract available
    
    
30. GELLERT FR, Gonzalez C, Mokdad AH
    Bridging the gap: A mixed-methods analysis of Canadian and U.S. immunization programs for enhancing racial equity in childhood vaccinations.
    Vaccine. 2025;57:127249.
    PubMed         Abstract available
    
    
31. ANYANGO RO, Nyawanda BO, Onyando BO, Haidara FC, et al
    Factors associated with laboratory-confirmed SARS-Cov-2 infection among patients with severe respiratory illness (SRI): Findings from the COVID-19 vaccine effectiveness evaluation in Kenya and Mali, 2022-2023.
    Vaccine. 2025 May 12:127234. doi: 10.1016/j.vaccine.2025.127234.
    PubMed         Abstract available
    
    
32. BOLOTIN S, Wright J, McLachlan E, Severini A, et al
    Investigating the measles susceptibility gap in Ontario infants.
    Vaccine. 2025;54:126908.
    PubMed         Abstract available
    
    
33. JAROVSKY D, Cereda RF, Figueiredo LM, Berezin EN, et al
    Epidemiology and clinical burden of invasive pneumococcal disease in older adults in the city of Sao Paulo, Brazil.
    Vaccine. 2025;54:126992.
    PubMed         Abstract available
    
    
34. HAO T, Ryan GE, Lydeamore MJ, Cromer D, et al
    Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19.
    Vaccine. 2025;55:126987.
    PubMed         Abstract available
    
    
35. PUTZ EJ, Andreasen CB, Stasko JA, Hamond C, et al
    Circulating foamy macrophages and other features of bacillus Calmette-Guerin challenge in Golden Syrian hamsters.
    Vaccine. 2025;55:127037.
    PubMed         Abstract available
    
    
36. XIE F, Du K, Li J, Zhong S, et al
    Head-to-head immunogenicity comparison of one-dose Cecolin and Gardasil in Chinese girls aged 9-14 years: A randomized and open-label clinical trial.
    Vaccine. 2025;55:127015.
    PubMed         Abstract available
    
    
37. PATRICK E, Iuliano A, Bakare D, Salako J, et al
    Non-specific effects of routine vaccinations on child survival between 12-59 months of age in Jigawa, Nigeria: A secondary analysis of the INSPIRING Jigawa trial.
    Vaccine. 2025;57:127211.
    PubMed         Abstract available
    
    
38. NAVARRETE JAY, Rodriguez D, Kanno AI, de Cerqueira Leite LC, et al
    Modulation of immune responses induced by recombinant BCG expressing LTAK63 adjuvant in an immunotherapeutic model vaccine.
    Vaccine. 2025;57:127215.
    PubMed         Abstract available
    
    
39. NTAKIYISUMBA E, Tanveer M, Won G
    A comprehensive analysis of the current strategy for developing live attenuated vaccines against African swine fever: A systematic review and meta-analysis.
    Vaccine. 2025;57:127243.
    PubMed         Abstract available
    
    
40. CARTER DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, et al
    Corrigendum to "Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine" [Vaccine (2015) 33(1) 108-16].
    Vaccine. 2025;57:127174.
    PubMed        
    
    
41. SAXTON P, Hollingshead BM, Rich J, Saini S, et al
    Mpox vaccine eligibility, uptake and coverage among gay, bisexual and other men who have sex with men in Aotearoa New Zealand.
    Vaccine. 2025;57:127247.
    PubMed         Abstract available
    
    
42. HU J, Cao H, Luan N, Zhang X, et al
    Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity.
    Vaccine. 2025;57:127241.
    PubMed         Abstract available
    
    
43. ANGULO M, Ramos-Vega A, Angulo C
    Trained immunity-based Adjuvated vaccines (TIbAV) approach: beta-glucans as example.
    Vaccine. 2025;57:127240.
    PubMed         Abstract available
    
    
44. MACLENNAN CA, Cunningham AF, Dean JE, Pope S, et al
    BactiVac, the Bacterial Vaccines Network.
    Vaccine. 2025;57:127210.
    PubMed         Abstract available
    
    
45. XIONG Y, Wu C, Zhang Y, Guo D, et al
    Can levels of HPV vaccine knowledge mitigate HPV vaccine hesitation among guardians of children aged 9-14 years? A moderated mediation model.
    Vaccine. 2025;57:127208.
    PubMed         Abstract available
    
    
46. KIM GL, Pyo SW, Kim SH, Song HJ, et al
    Serological correlates of protection and long-term efficacy of a novel recombinant protective antigen-based anthrax vaccine in a rabbit model.
    Vaccine. 2025;57:127212.
    PubMed         Abstract available
    
    
47. ADAME BJ, Corman SR, Von Feldt PA, Meneses CM, et al
    Reactance as a cause of COVID-19 vaccination hesitancy.
    Vaccine. 2025;57:127209.
    PubMed         Abstract available
    
    
48. ROULEAU I, Issa Kana KDN, Zafack JG, Viger YB, et al
    New-onset anesthesia/paresthesia following the administration of COVID-19 vaccines in Quebec, Canada.
    Vaccine. 2025;57:127217.
    PubMed         Abstract available
    
    
49. ZHENG F, Zhu M, Ran H, He J, et al
    Assessment of recombinant Lactobacillus vector-based expressing IFITM3 protein anti-PRV infection in mice.
    Vaccine. 2025;54:127093.
    PubMed         Abstract available
    
    
50. MEESTERS K, Sadarangani M, Clark SA, Borrow R, et al
    Characterization of Canadian Neisseria meningitidis serogroup B isolates and factor-H binding protein expression, data from the Canadian Immunization Monitoring Program Active (IMPACT), 2013-2020.
    Vaccine. 2025;55:127030.
    PubMed         Abstract available
    
    
51. GAGNON D, Gubany C, Ouakki M, Malo B, et al
    Factors influencing acceptance of RSV immunization for newborns among pregnant individuals: A mixed-methods study.
    Vaccine. 2025;55:127062.
    PubMed         Abstract available
    
    
52. VYSOTSKAYA V, Gassowski M, Kasper A, Gasich E, et al
    Hepatitis B serosurvey to validate the achievement of regional hepatitis B control targets in Belarus.
    Vaccine. 2025;55:127058.
    PubMed         Abstract available
    
    
53. SOTO-NOGUERON A, Carnalla-Barajas MN, Sanchez-Gonzalez G, Solorzano-Santos F, et al
    Distribution of pneumococcal serotypes causing invasive and non-invasive diseases in children in Mexico after introduction of PCV13 (2012-2023). Results from the GIVEBPVac group.
    Vaccine. 2025;55:127031.
    PubMed         Abstract available
    
    

    
    Virology

54. XU J, Zhang B, Wang B, Ye Z, et al
    The PB subunit vaccine evokes immune response against fox encephalitis.
    Virology. 2025;609:110561.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.